A 60-year-old Danish woman who received the AstraZeneca COVID-19 vaccine experienced “highly unusual symptoms” before dying from a blood clot, according to a report.
The woman had a low number of blood platelets and clots in small and large vessels, Reuters reported, citing the Danish Medicines Agency.
The agency cited some similar cases reported in Norway and in the European Medicines Agency’s database on side effects of medicines, according to the media.
“It was an unusual course of illness around death that caused the Danish Medicines Agency to react,” the agency said in a statement late on Sunday.
On Saturday, Norway said three people – all under 50 – who received the injection were being treated in a hospital for bleeding, blood clots and low platelet counts, which health officials labeled “unusual symptoms”.
Denmark, Norway and Iceland said last week that they would halt the introduction of the AstraZeneca shot.
European vaccination programs have been shaken by recent reports that recipients of the AstraZeneca inoculation have suffered blood clots.
The European Medicines Agency said there was no evidence that the cases were related to vaccination, an opinion that was shared by the World Health Organization on Friday.
AstraZeneca tried to suppress safety concerns after blood clots broke out in some people, prompting about a dozen nations to stop using some or all of their doses.
The British pharmaceutical’s analysis of the safety data of more than 17 million people who received the injection in the UK and the European Union found no evidence of an increased risk of pulmonary embolism or deep vein thrombosis, conditions associated with clots, he said in one communicated on Sunday.
There were also no signs of an increased risk of thrombocytopenia, a low blood platelet count, according to AstraZeneca.